Adial Pharmaceuticals, Inc. (ADIL): Total Assets
$6.67M
As of 2025-12-31
$29.09M
As of 2026-06-30
+5.2%
3-year compound annual growth
+4.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.67M | +32.3% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $5.04M | +6.5% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $4.74M | -17.4% | 2025-03-04, Balance as of period end |
| 2022-12-31 | $5.73M | -23.3% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $7.47M | +36.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $5.49M | -28.5% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $7.68M | +63.4% | 2021-03-22, Balance as of period end |
| 2018-12-31 | $4.70M | n/m | 2020-03-20, Balance as of period end |
| 2017-12-31 | $34.5K | n/a | 2019-02-19, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Adial Pharmaceuticals, Inc. (ADIL) | 2025-12-31 | $6.67M | +32.3% |
| Kairos Pharma, Ltd. (KAPA) | 2025-12-31 | $6.54M | +13.4% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $6.84M | +23.5% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.95M | +3.4% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $6.96M | -12.2% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $6.34M | -22.2% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $7.21M | -43.0% |
Compare ADIL, KAPA, OSTX, HIND side by side · Screen every company in Pharmaceutical Preparations ↗